At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:10 ET
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 3,425,993 shares of Ascendis Pharma A/S common stock as of September 30, 2026, representing 5.2% of shares outstanding. This is a routine passive stake update with no change in the percentage from the prior filing period, indicating Fidelity maintained its position.
- FMR LLC reported beneficial ownership of 3,425,993 shares of Ascendis Pharma A/S common stock as of September 30, 2026.
- The stake represents 5.2% of the total outstanding common stock.
- The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
- Abigail P. Johnson is also reported as a beneficial owner of the same 3,425,993 shares (5.2%) due to her control of FMR LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access